Selected research
Industry Research
Isotopes for Nuclear Medicine Industry Research Report 2026
Market perspective
The global Isotopes for Nuclear Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Isotopes for Nuclear Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Isotopes for Nuclear Medicine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Isotopes for Nuclear Medicine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Isotopes for Nuclear Medicine include Urenco, SHINE Medical, NTP Radioisotopes, Northwest Medical Isotopes, Medical Isotopes, ITM, CMR and Cambridge Isotope Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Isotopes for Nuclear Medicine market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Isotopes for Nuclear Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Isotopes for Nuclear Medicine Market by Company
Urenco
SHINE Medical
NTP Radioisotopes
Northwest Medical Isotopes
Medical Isotopes
ITM
CMR
Cambridge Isotope Laboratories
Isotopes for Nuclear Medicine Segment by Type
Stable Isotope
Radioisotope
Isotopes for Nuclear Medicine Segment by Application
Hospital
Laboratory
Others
Isotopes for Nuclear Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isotopes for Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isotopes for Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isotopes for Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Isotopes for Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stable Isotope
- Radioisotope
Applications
- Hospital
- Laboratory
- Others
Companies covered
- Urenco
- SHINE Medical
- NTP Radioisotopes
- Northwest Medical Isotopes
- Medical Isotopes
- ITM
- CMR
- Cambridge Isotope Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Isotopes for Nuclear Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stable Isotope
- 2.2.3 Radioisotope
- 2.3 Isotopes for Nuclear Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Isotopes for Nuclear Medicine Breakdown Data by Type
- 3.1 Global Isotopes for Nuclear Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Isotopes for Nuclear Medicine Forecasted Market Size by Type (2027-2032)
4 Isotopes for Nuclear Medicine Breakdown Data by Application
- 4.1 Global Isotopes for Nuclear Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Isotopes for Nuclear Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Isotopes for Nuclear Medicine Market Perspective (2021-2032)
- 5.2 Global Isotopes for Nuclear Medicine Growth Trends by Region
- 5.2.1 Global Isotopes for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Isotopes for Nuclear Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Isotopes for Nuclear Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Isotopes for Nuclear Medicine Market Dynamics
- 5.3.1 Isotopes for Nuclear Medicine Industry Trends
- 5.3.2 Isotopes for Nuclear Medicine Market Drivers
- 5.3.3 Isotopes for Nuclear Medicine Market Challenges
- 5.3.4 Isotopes for Nuclear Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Isotopes for Nuclear Medicine Players by Revenue
- 6.1.1 Global Top Isotopes for Nuclear Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Isotopes for Nuclear Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Isotopes for Nuclear Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Isotopes for Nuclear Medicine Head Office and Area Served
- 6.4 Global Isotopes for Nuclear Medicine Players, Product Type & Application
- 6.5 Global Isotopes for Nuclear Medicine Manufacturers Established Date
- 6.6 Global Isotopes for Nuclear Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Isotopes for Nuclear Medicine Market Size (2021-2032)
- 7.2 North America Isotopes for Nuclear Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 7.4 North America Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Isotopes for Nuclear Medicine Market Size (2021-2032)
- 8.2 Europe Isotopes for Nuclear Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 8.4 Europe Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Isotopes for Nuclear Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Isotopes for Nuclear Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Isotopes for Nuclear Medicine Market Size (2021-2032)
- 10.2 South America Isotopes for Nuclear Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 10.4 South America Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Isotopes for Nuclear Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Isotopes for Nuclear Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Urenco
- 12.1.1 Urenco Company Information
- 12.1.2 Urenco Business Overview
- 12.1.3 Urenco Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.1.4 Urenco Isotopes for Nuclear Medicine Product Portfolio
- 12.1.5 Urenco Recent Developments
- 12.2 SHINE Medical
- 12.2.1 SHINE Medical Company Information
- 12.2.2 SHINE Medical Business Overview
- 12.2.3 SHINE Medical Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.2.4 SHINE Medical Isotopes for Nuclear Medicine Product Portfolio
- 12.2.5 SHINE Medical Recent Developments
- 12.3 NTP Radioisotopes
- 12.3.1 NTP Radioisotopes Company Information
- 12.3.2 NTP Radioisotopes Business Overview
- 12.3.3 NTP Radioisotopes Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.3.4 NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio
- 12.3.5 NTP Radioisotopes Recent Developments
- 12.4 Northwest Medical Isotopes
- 12.4.1 Northwest Medical Isotopes Company Information
- 12.4.2 Northwest Medical Isotopes Business Overview
- 12.4.3 Northwest Medical Isotopes Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.4.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 12.4.5 Northwest Medical Isotopes Recent Developments
- 12.5 Medical Isotopes
- 12.5.1 Medical Isotopes Company Information
- 12.5.2 Medical Isotopes Business Overview
- 12.5.3 Medical Isotopes Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.5.4 Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 12.5.5 Medical Isotopes Recent Developments
- 12.6 ITM
- 12.6.1 ITM Company Information
- 12.6.2 ITM Business Overview
- 12.6.3 ITM Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.6.4 ITM Isotopes for Nuclear Medicine Product Portfolio
- 12.6.5 ITM Recent Developments
- 12.7 CMR
- 12.7.1 CMR Company Information
- 12.7.2 CMR Business Overview
- 12.7.3 CMR Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.7.4 CMR Isotopes for Nuclear Medicine Product Portfolio
- 12.7.5 CMR Recent Developments
- 12.8 Cambridge Isotope Laboratories
- 12.8.1 Cambridge Isotope Laboratories Company Information
- 12.8.2 Cambridge Isotope Laboratories Business Overview
- 12.8.3 Cambridge Isotope Laboratories Revenue in Isotopes for Nuclear Medicine Business (2021-2026)
- 12.8.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio
- 12.8.5 Cambridge Isotope Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst